Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice (Q77357398)
Jump to navigation
Jump to search
scientific article published on 01 November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice |
scientific article published on 01 November 2001 |
Statements
Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice (English)
Leishmania major
1 reference
J E Uzonna
P A Bretscher
1 November 2001